Charles Flexner, MD, from Johns Hopkins University answers our questions about aging in HIV, long-acting antiretroviral therapy, and at-risk populations.
Charles Flexner, MD, from Johns Hopkins University answers our questions about aging in HIV, long-acting antiretroviral therapy, and at-risk populations.
Daniel Beard, PhD, and colleagues from the University of Oxford studied the potential effects of rapamycin on infarct volume in animal models. Here are his responses to 5 of our burning questions.
Daniel Beard, PhD, and colleagues from the University of Oxford studied the potential effects of rapamycin on infarct volume in animal models. Here are his responses to 5 of our burning questions.
Daniel Beard, PhD, and colleagues from the University of Oxford studied the potential effects of rapamycin on infarct volume in animal models. Here are his responses to 5 of our burning questions.
Consultant360 spoke with Adam Chekroud, PhD, of Spring Health and Yale School of Medicine, who recently led a study investigating the frequency, duration, and types of exercise that confer the most mental...
Consultant360 spoke with Adam Chekroud, PhD, of Spring Health and Yale School of Medicine, who recently led a study investigating the frequency, duration, and types of exercise that confer the most mental...
Consultant360 spoke with Adam Chekroud, PhD, of Spring Health and Yale School of Medicine, who recently led a study investigating the frequency, duration, and types of exercise that confer the most mental...
Although CVD risk is known to spike significantly during the menopausal transition, new research suggests that practicing certain healthy behaviors in midlife can help lessen this risk. Consultant360...
Although CVD risk is known to spike significantly during the menopausal transition, new research suggests that practicing certain healthy behaviors in midlife can help lessen this risk. Consultant360...
